Visual and quantitative approach to bone marrow foci of increased glucose uptake on PET/CT in a case of aplastic anaemia

F. Cicone; M. Stalder; D. Geiger; A. Cairoli; A. Bischof Delaloye; J. O. Prior

doi:10.1055/s-0038-1626489

Nuklearmedizin - NuclearMedicine, Table of Contents

Nuklearmedizin 2010; 49(02): N10-N12
DOI: 10.1055/s-0038-1626489

Case report

Schattauer GmbH

Visual and quantitative approach to bone marrow foci of increased glucose uptake on PET/CT in a case of aplastic anaemia

F. Cicone

¹Sant' Andrea Hospital, Nuclear Medicine Department, University La Sapienza, Rome, Italy

⁵Nuclear Medicine, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Switzerland

,

M. Stalder

²Service of Hematology, Institut Central des Hôpitaux Valaisans, Sion, Switzerland

,

D. Geiger

³General Practitioner, Conthey, Switzerland

,

A. Cairoli

⁴Service of Hematology, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Switzerland

,

A. Bischof Delaloye

⁵Nuclear Medicine, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Switzerland

,

J. O. Prior

⁵Nuclear Medicine, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Switzerland

› Author Affiliations

Abstract

Full Text

References

References
1 Amano Y, Kumazaki T. Quantitative and qualitative assessment of reactive hematopoietic bone marrow in aplastic anemia using MR spectroscopy with variable echo times. Skeletal Radiol 2002; 31: 19-24.
2 Basu S, Houseni M, Bural G. et al. Magnetic resonance imaging based bone marrow segmentation for quantitative calculation of pure red marrow metabolism using 2-deoxy-2-[¹⁸F]fluoro-D-glucose-positron emission tomography: a novel application with significant implications for combined structure-function approach. Mol Imaging Biol 2007; 9: 361-365.
3 Cicone F, Loose D, Deron P. et al. Prognostic value of FDG uptake by the bone marrow in squamous cell carcinoma of the head and neck. Nucl Med Commun 2008; 29: 431-435.
4 Cicone F, Signore A, Scopinaro F. Studying the metabolic activity of red bone marrow by means of FDG-PET: the need for a standardization. Mol Imaging Biol 2008; 10: 129-130.
5 Doot RK, Dunnwald LK, Schubert EK. et al. Dynamic and static approaches to quantifying ¹⁸F-FDG uptake for measuring cancer response to therapy, including the effect of granulocyte CSF. J Nucl Med 2007; 48: 920-925.
6 Huang SC. Anatomy of SUV. Standardized uptake value. Nucl Med Biol. 2000; 27: 643-646.
7 Gupta G, Robertson P, Szer J. Focal lesions on magnetic resonance imaging in aplastic anaemia: multiple metastases or haemopoietic marrow. Australas Radiol 2007; 51: B110-114.
8 Kaplan PA, Asleson RJ, Klassen LW. et al. Bone marrow patterns in aplastic anemia: observations with 1.5-T MR imaging. Radiology. 1987; 164: 441-444.
9 Kouba M, Maaloufova J, Campr V. et al. G-CSF stimulated islands of haematopoiesis mimicking disseminated malignancy on PET-CT and MRI scans in a patient with hypoplastic marrow disorder. Br J Haematol 2005; 130: 807.
10 Krause BJ, Beyer T, Bockisch A. et al. FDG-PET/CT in oncology. German Guideline. Nuklearmedizin 2007; 46: 291-301.
11 McKinstry CS, Steiner RE, Young AT. et al. Bone marrow in leukemia and aplastic anemia: MR imaging before, during, and after treatment. Radiology 1987; 162: 701-707.
12 Murata Y, Kubota K, Yukihiro M. et al. Correlations between ¹⁸F-FDG uptake by bone marrow and hematological parameters: measurements by PET/CT. Nucl Med Biol 2006; 33: 999-1004.
13 Prevost S, Boucher L, Larivee P, et al. Bone marrow hypermetabolism on ¹⁸F-FDG PET as a survival prognostic factor in non-small cell lung cancer. J Nucl Med 2006; 47: 559-565.
14 Stergar H, Bockisch A, Eschmann SM. et al. Influence of PET/CT-introduction on PET scanning frequency and indications. Results of a multicenter study. Nuklearmedizin 2007; 46: 57-64.
15 Teo BK, Badiee S, Hadi M. et al. Correcting tumour SUV for enhanced bone marrow uptake: retrospective ¹⁸F-FDG PET/CT studies. Nucl Med Commun 2008; 29: 359-366.
16 Van de Wiele C, Vande Vyver F, Debruyne C. et al. FDG uptake by the bone marrow in NSCLC patients is related to TGF-beta but not to VEGF or G-CSF serum levels. Eur J Nucl Med Mol Imaging 2008; 35: 519-522.